As of June 8, 2025, Heska Corp (HSKA) reports a EV/EBITDA of -221.51.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Heska Corp's EV/EBITDA to Peers
To better understand Heska Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Heska Corp (HSKA) | -221.51 |
| AxoGen Inc (AXGN) | 69.56 |
| Intuitive Surgical Inc (ISRG) | 64.79 |
| Dexcom Inc (DXCM) | 41.92 |
| Boston Scientific Corp (BSX) | 39.50 |
| IDEXX Laboratories Inc (IDXX) | 33.84 |
Compared to its competitors, Heska Corp's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.